Trial Profile
A study to demonstrate change in the number of C. difficilevegetative cells and spores in stool of patients with C.difficile infection (CDI) receiving fidaxomicin (FDX) or vancomycin (VAN).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Fidaxomicin (Primary) ; Vancomycin (Primary)
- Indications Clostridium difficile infections
- Focus Therapeutic Use
- 18 Dec 2015 New trial record